KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
KemPharm (KMPH) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : $29.72 M
According to KemPharm's latest financial reports the company's total liabilities are $29.72 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
KemPharm - Total liabilities on balance sheet (from 2014 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $29.72 M | 410.42% |
| 2021-12-31 | $5.82 M | -92.5% |
| 2020-12-31 | $77.62 M | -8.64% |
| 2019-12-31 | $84.96 M | -8.95% |
| 2018-12-31 | $93.31 M | -15.15% |
| 2017-12-31 | $0.10 B | 6.17% |
| 2016-12-31 | $0.10 B | 57.32% |
| 2015-12-31 | $65.84 M | 73.2% |
| 2014-12-31 | $38.01 M | 42.4% |
| 2013-12-31 | $26.69 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | $0.16 B | 468.62% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | $7.63 B | 25,573.27% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | $0.44 B | 1,403.34% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $26.57 M | -10.59% | 🇺🇸 USA |